Clin2
NCT06446648Possibly a fitRecruiting

Green dye to improve recovery after prostate cancer surgery

Prostate Adenocarcinoma

Treatments studied

Part of Cancer, Kidney & urinary clinical trials.

This trial tests whether using a green dye (ICG) during robot-assisted prostate removal helps preserve urinary and sexual function. It is for men with localized prostate cancer and good baseline erectile function.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be a man 18 years or older with prostate cancer that has not spread outside the prostate.
  • Have a recent erectile function score (SHIM) of 10 or higher.
  • Be a good candidate for nerve-sparing surgery, as decided by your surgeon.
  • Not have used injections or a penile implant for erectile dysfunction (oral pills are fine).
  • Not have had prior prostate cancer treatments like hormone therapy, radiation, or focal therapy.
  • Not be allergic to iodine, ICG dye, or shellfish.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07000539Recruiting
Green dye test in repeat weight loss surgery

This trial tests if a green dye, injected during repeat weight loss surgery, helps surgeons see blood flow better. It may reduce complications for people having a second bariatric procedure.

Tijuana, Estado de Baja California
NCT06945718Recruiting
Green dye test for gastric cancer surgery

This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.

Fuzhou, Fujian
NCT06421220Not yet recruiting
Green dye during keyhole surgery for stomach cancer

This study tests whether using a green dye (called indocyanine green) during keyhole surgery helps doctors find and remove lymph nodes more accurately in stomach cancer. It may help reduce the chance of leaving cancer behind.

Jinan, Shandong
NCT06892392Not yet recruiting
Green dye for lymph node removal in stomach cancer surgery

This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.

Pamplona, Navarre
NCT06755554Recruiting· Phase 3
Green dye to guide lymph node removal in stomach cancer surgery

This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.

Kyiv
NCT06708819Not yet recruiting
Green dye imaging to improve bowel surgery outcomes

This trial tests a special green dye that helps surgeons see blood flow in the bowel during surgery. It may help reduce complications after removing part of the bowel for diseases like cancer or diverticulitis.

Dublin

Hear when a new Prostate Adenocarcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.